Joshua Schafer Appointed as Interim Chairman of Pharnext Board of Directors

PARIS, FRANCE / ACCESSWIRE / March 30, 2022 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics …